Literature DB >> 2165161

Synthesis and antiviral activity of monofluoro and difluoro analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1).

J A Martin1, D J Bushnell, I B Duncan, S J Dunsdon, M J Hall, P J Machin, J H Merrett, K E Parkes, N A Roberts, G J Thomas.   

Abstract

A range of 2'-fluoro and 2',3'-difluoro analogues of pyrimidine deoxyribonucleosides have been synthesized and evaluated against human immunodeficiency virus (HIV-1) in a human lymphoblastoid cell line. Among these compounds, 1-(2,3-dideoxy-2-fluoro-beta-D-threopentofuranosyl)cytosine (12), 2',3'-didehydro-2',3'-dideoxy-2'-fluorocytidine (35), 1-(2,3-dideoxy-2,3-difluoro-beta-D-arabinofuranosyl)cytosine (41), and 3'-deoxy-2',3'-didehydro-2'-fluorothymidine (45) were found to have significant antiviral activity, with IC50 values of 0.65, 10, 10, and 100 microM, respectively. The structure-activity relationships are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165161     DOI: 10.1021/jm00170a015

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Synthesis and antiviral activity of purine 2',3'-dideoxy-2',3'-difluoro-D-arabinofuranosyl nucleosides.

Authors:  Grigorii G Sivets; Elena N Kalinichenko; Igor A Mikhailopulo; Mervi A Detorio; Tami R McBrayer; Tony Whitaker; Raymond F Schinazi
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-05       Impact factor: 1.381

2.  Studies toward the oxidative and reductive activation of C-S bonds in 2'-S-aryl-2'-thiouridine derivatives.

Authors:  Ramanjaneyulu Rayala; Alain Giuglio-Tonolo; Julie Broggi; Thierry Terme; Patrice Vanelle; Patricia Theard; Maurice Médebielle; Stanislaw F Wnuk
Journal:  Tetrahedron       Date:  2016-04-21       Impact factor: 2.457

3.  Anti-human immunodeficiency virus activities of nucleosides and nucleotides: correlation with molecular electrostatic potential data.

Authors:  T Mickle; V Nair
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 4.  Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.

Authors:  J Balzarini
Journal:  Pharm World Sci       Date:  1994-04-15

Review 5.  Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS).

Authors:  R Whittington; R N Brogden
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

6.  Impact of sugar pucker on base pair and mispair stability.

Authors:  Adides A Williams; Agus Darwanto; Jacob A Theruvathu; Artur Burdzy; Jonathan W Neidigh; Lawrence C Sowers
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

7.  Synthesis, evaluation of anti-HIV-1 and anti-HCV activity of novel 2',3'-dideoxy-2',2'-difluoro-4'-azanucleosides.

Authors:  Saúl Martínez-Montero; Susana Fernández; Yogesh S Sanghvi; Emmanuel A Theodorakis; Mervi A Detorio; Tamara R McBrayer; Tony Whitaker; Raymond F Schinazi; Vicente Gotor; Miguel Ferrero
Journal:  Bioorg Med Chem       Date:  2012-09-23       Impact factor: 3.641

8.  Comprehensive structural studies of 2',3'-difluorinated nucleosides: comparison of theory, solution, and solid state.

Authors:  Joseph J Barchi; Rajeshri G Karki; Marc C Nicklaus; Maqbool A Siddiqui; Clifford George; Igor A Mikhailopulo; Victor E Marquez
Journal:  J Am Chem Soc       Date:  2008-06-18       Impact factor: 15.419

9.  Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents.

Authors:  Katharigatta N Venugopala; Reshme Govender; Mohammed A Khedr; Rashmi Venugopala; Bandar E Aldhubiab; Sree Harsha; Bharti Odhav
Journal:  Drug Des Devel Ther       Date:  2015-02-17       Impact factor: 4.162

10.  Design, synthesis, and biological evaluation of novel iso-D-2',3'-dideoxy-3'-fluorothianucleoside derivatives.

Authors:  Kyung Ran Kim; Hyung Ryong Moon; Ah-Young Park; Moon Woo Chun; Lak Shin Jeong
Journal:  Bioorg Med Chem       Date:  2006-09-30       Impact factor: 3.641

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.